Top Related
Treatment Naïve and Treatment Experienceddepts.washington.edu/hepstudy/presentations/uploads/82/cosmos.pdf · Simeprevir + Sofosbuvir +/- Ribavirin in Genotype 1 COSMOS Trial Phase
Phase 3 - University of Washingtondepts.washington.edu/hepstudy/presentations/... · Abbreviations: DCV = daclatasvir; SOF = sofosbuvir 97 78 100 89 50 92 0 20 40 60 80 100 Treatment
Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1 … › hepstudy › presentations › ...Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 A1444040 Trial
State of the Art Therapy for HCV - University of Washingtondepts.washington.edu/hepstudy/presentations/...• Favorable clinical pharmacology profile - No food effect - No significant
Natural History of Hepatitis C Infectiondepts.washington.edu/hepstudy/presentations/... · Natural History of Hepatitis C Infection Recorded on May 15, 2013 . Slide 2 of 16 Disclosure
Treatment of Hepatitis C in Patients with Renal Insufficiencydepts.washington.edu/hepstudy/presentations/... · Hepatitis C Treatment Issues Related to Renal Disease • Hepatitis
Phase 3 - depts.washington.edudepts.washington.edu/hepstudy/presentations/uploads/164/ally3.pdf · Hepatitis Source: Nelson DR, et al. Hepatology 2015;61:1127-35. web study Treatment-Experienced
ION-4 - University of Washingtondepts.washington.edu/hepstudy/presentations/uploads/149/ion4_ls.pdfION-4 Trial: Features ION-4 Trial Design: Open-label, single group, phase 3 trial,